The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia
Abstract
INTRODUCTION: Cancer cachexia is a complex multifaceted syndrome involving functional impairment, changes in body composition, and nutritional disorders. The treatment of cancer cachexia can be based on these three domains of the syndrome. Phase II and III trials of anamorelin, a ghrelin mimetic agent, have been shown to increase body weight in patients with cancer cachexia, mainly by increasing muscle and fat mass. Anamorelin has been shown to improve anorexia scores. AREAS COVERED: This review aims to outline the effect of anamorelin on body composition and functional parameters as well as to discuss the clinical importance of these alterations in patients with cancer cachexia. EXPERT OPINION: To date, there is no treatment approved to enhance body composition and functional parameters in patients with cancer cachexia. Anamorelin, the most advanced therapy to treat cachexia, has not yielded convincing results in all aspects of the syndrome. In particular, no effect has been noted on physical function and long-term survival. Along with these essential improvements for future interventions with anamorelin, subsequent studies must address other etiologies of cancer, rather than non-small cell lung cancer, and add complementary therapies, such as exercise training and nutritional interventions, in an attempt to overcome cancer cachexia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This oral ghrelin analogue has mostly been studied in cancer217–219 and has anti-inflammatory and anabolic properties.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [218]
Citations
Cites
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767
Ghrelin induces adiposity in rodents
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949
Cederholm, T., Jensen, G. L., Correia, M. I. T. D., Gonzalez, M. C., Fukushima, R., Higashiguchi, T., Baptista, G., Barazzoni, R., Blaauw, R., Coats, A., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.002 · Cited by 3,022
Prognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354
Cowley, M. A., Smith, R. G., Diano, S., Tschöp, M., Pronchuk, N., Grove, K. L., Strasburger, C. J., Bidlingmaier, M., Esterman, M., Heiman, M. L., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00063-1 · Cited by 1,679
Cermak, N. M., Res, P. T., de Groot, L. C., Saris, W. H., & van Loon, L. J. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.037556 · Cited by 827
Update on the effects of physical activity on insulin sensitivity in humans
Bird, S. R., & Hawley, J. A. (2017) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2016-000143 · Cited by 646
Temel, J. S., Abernethy, A. P., Currow, D. C., Friend, J., Duus, E. M., Yan, Y., & Fearon, K. C. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00558-6 · Cited by 639
Neary, N. M., Small, C. J., Wren, A. M., Lee, J. L., Druce, M. R., Palmieri, C., Frost, G. S., Ghatei, M. A., Coombes, R. C., & Bloom, S. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031768 · Cited by 456
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
Peixoto da Silva, S., Santos, J. M. O., Costa e Silva, M. P., Gil da Costa, R. M., & Medeiros, R. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12528 · Cited by 371
Research works printed but not linked: 6
- Cole CL, 2018, JCSM Clin Rep, 3
- Fonseca GWPD, 2020, Int J Mol Sci, 21(7):2321
- Dev R, 2017, Oncology (Williston Park), 31, 23
- Shimizu Y, 2003, Clin Cancer Res, 9, 774
- Porporato PE, 2013, J Clin Invest, 123, 611
- Mitchell T, 2019, Healthcare (Basel), 7(3):89
Cited by
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
Anorexia of Aging: Metabolic Changes and Biomarker Discovery
Picca, A., Calvani, R., Coelho‐Júnior, H. J., Landi, F., & Marzetti, E. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s325008 · Cited by 54
Mareschal, J., Hemmer, A., Douissard, J., Dupertuis, Y. M., Collet, T., Koessler, T., Toso, C., Ris, F., & Genton, L. (2023) · Cancers · doi:10.3390/cancers15061881 · Cited by 43
“However, the first data available in other settings are quite promising, and these recent innovations could be evaluated in well-designed studies [70].”
BackgroundMechanisms of cancer cachexia and targeted therapeutic strategies
Li, L., & Ling, Z. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189208 · Cited by 30
Metabolomics‐driven discovery of therapeutic targets for cancer cachexia
Cui, P., Li, X., Huang, C., & Lin, D. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13465 · Cited by 22
“Progestins have not been shown to signi fi cantly increase lean body mass. 107 In a signi fi cant development, Japan approved anamorelin in 2020 to treat CC, marking the fi rst such approval for this condition.”
Background
Metadata
- Authors
- Fonseca, G. W. P. D., & von Haehling, S.
- Affiliations
- Universidade de São Paulo (BR)
- Department of Cardiology and Pneumology, University of Göttingen Medical Center (UMG), Göttingen, Germany;s German Centre for Cardiovascular Research (DZHK) Partner Site Göttingen, Göttingen, Germany
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa UK Limited
- Published
- 2021-01-25
- Volume
- 22
- Issue
- 7
- Pages
- 889-895
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W3122969614
- Cited by
- 25
- References
- 64
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 6 · 2022: 6 · 2021: 4
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Pharmacotherapy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brazil
- German Center for Cardiovascular Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- anamorelin, cancer cachexia, ghrelin receptor agonist, body composition, muscle mass, fat mass, physical function, non-small cell lung cancer, dietary intervention, exercise training
- MeSH terms
- Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Humans, Hydrazines, Lung Neoplasms, Neoplasms, Oligopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia. https://app.cochat.ai/papers/10.1080/14656566.2021.1873954
- The paper
- Fonseca, G. W. P. D., & von Haehling, S. (2021). An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia. Expert Opinion on Pharmacotherapy. https://doi.org/10.1080/14656566.2021.1873954
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.